Trazadone associated with SSRIs and SNRIs in depressed patients with anxiety and insomnia;Trazodona combinada con ISRS e ISRN en pacientes deprimidos que presentan ansiedad e insomnio

Psiquiatria Biologica

Volumn 14, Issue 6, 2007, Pages 204-210

  Llàcer, José María Bonete ^a   Gandia I Esplà, Ricard ^b   Matarredona Català, José ^c,e   Martínez, Enrique Pérez ^d  

^a Unidad de Salud Mental   (Spain)

^b HOSPITAL VIRGEN DE LOS LIRIOS   (Spain)

^c Departamento de Salud de Alcoy   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e C S La Fábrica   (Spain)

Author keywords

Anxiety; Depression; Insomnia; SNRIs; SSRIs; Trazodone

Indexed keywords

CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HAMILTON ANXIETY SCALE; HEADACHE; HEALTH SURVEY; HUMAN; INSOMNIA; MIGRAINE; NAUSEA; PARAMETER; QUALITY OF LIFE; RATING SCALE; REST; SEDATION; SELF CONCEPT; SIDE EFFECT; SLEEP TIME; SOMNOLENCE; STATISTICAL ANALYSIS; SYMPTOM;

EID: 37349128941     PISSN: 11345934     EISSN: 15788962     Source Type: Journal    
DOI: 10.1016/S1134-5934(07)73286-4     Document Type: Article

References (53)

1. Stahl SM. Essential psychopharmacology Neuroscientific basis and practical applications. Cambridge: Cambrige University Press; 2000.
2. Stahl SM. Basic psychopharmacology af antidepressants, part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry. 1998;59 Suppl 4:5-24.
3. Furlan PM, Picci RL, Lazaarini R, et al. Trazodone: metanalisi dei dati di efficacia nel trattamento della depressione e nuove prospettive terapeutiche. Proceedings of the Congress "Farmaci Innovativi: gli Antidepressivi". Roma: Istututo Superiore di Sanità; 2003.
4. Patten SB. The comparative efficacy of trazodone and imipramine in the treatment of depression. Can Med Assoc J. 1992;146:1177-82.
5. Goldberg HL, Finnerty RJ. Trazodone in the treatment of neurotic depression. J Clin Psychiatry 1980;41:430-4.
6. Beasley CM Jr, Dornself BE, Pultz JA, et al. Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry. 1991;52:294-9.
7. Namiki M, Eiji M, Minemoto H, et al. A clinical phase III study of SME3110 (fluoxetine maleate) in depressed patients at the Department of Internal Medicine. A double blind, comparative study with trazodone hydrochloride. J Clin Psychiatry. 1996;12:651-77.
8. Kasper S, Olivieri L, Di Loreto G, et al. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder. Curr Med Res Opin. 2005;21:1139-46.
9. Tsutsui SA, Okuse S, Sasaki D, et al. A clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor, in the treatment of depression and depressive state. Jpn J Neuropsychopharmacol. 1997;19:549-68.
10. Papakostas G, Fava M. A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. Eur Psychiatry. 2007;22:444-7.
11. Levi G. Depressive disorder in pre-adolescence: comorbidity or different clinical subtypes? (A pharmacological contribution). Isr J Psychiatry Relat Sci 1997;34:187-94.
12. Rickels K. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry. 1993;50:884-95.
13. Stella S. L'uso del trazodone per via endovenosa: uno studio clinico. Rivista di Psichiatria. 2001;35:1-7.
14. Sulzer DL. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry. 1997;5:60-9.
15. Zubieta JK. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children. J Clin Psychopharmacol. 1992;12:346-51.
16. Ansseau M. Trazodone in benzodiazepine dependence. J Clin Psychiatry. 1993;54:189-91.
17. Rickels K. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome. Psychopharmacology (Berl). 1999;141:1-5.
18. Janiri L. Adjuvant trazodone in the treatment of alcoholism: an open study. Alcohol Alcohol. 1998;33:362-5.
19. Le Bon O. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003;23:377-83.
20. Fink HA. Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU Int. 2003;92:441-6.
21. Gartrell N. Increased libido in women receiving trazodone. Am J Psychiatry. 1986;143:781-2.
22. Kurt U. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction. J Urol. 1994;152:407-9.
23. Montorsi F. Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. Urology, 1994;44:732-6.
24. Sáenz de Tejada I. Pathophysiology of prolonged penile erection associated with trazodone use. J Urol. 1991;145:60-4.
25. Ware JC. The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep. 1994;17:544-50.
26. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry. 1999;60 Suppl 17:28-31.
27. Saletu B. Pharmaco-EEG profiles of typical and atypical antidepressants. En: Costa E, Racagni G, editores. Typical and atypical antidepressants; clinical practice. New York: Raven Press; 1982. p. 257-68.
28. Yamadera H, Nakamura S, Suzuki H, et al. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci. 1998;52:439-43.
29. Montgomery I, Oswald I, Morgan K, Adam K. Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol. 1983;16:139-44.
30. Walsh JK, Erman M, Erwin CW, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia. Hum Psychopharmacol Clin Exp. 1998;13:191-8.
31. Mouret J, Lemoine P, Minuit MP, et al. Effect of trazodone on the sleep of depressed subjects -a polygraphic study. Psychopharmacology. 1988;95 Suppl:S37-43.
32. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 1994;151:1069-72.
33. Brunello N, Armitage R, Feinberg I, et al. Depression and sleep disorders: Clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology. 2000;42:107-19.
34. Oberndorfer S, Saletu-Zyhlarz G, Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neurophsychobioloby. 2000;42:69-81.
35. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia related to dysthymia: Comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology. 2001;44:139-49.
36. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P, et al. Insomnia in depression: Differences in objective and subjective sleep and awakening quality normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Bsychiatry. 2002;26:249-60.
37. Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B. Confirmation of the neuropshysiolocally predicted therapeutics effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology. 2003;48:194-208.
38. Doogan DP. Toleration and safety of sertraline: experience world-wide. Int Clin Psychopharmacol. 1991;6 Suppl 2:47-56.
39. Falk WE, Rosenbaum JF, Otto MW, et al. Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol. 1989;2:208-14.
40. Murdoch D, McTavish D. Sertraline a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsesive-compulsive disorder. Drugs. 1992;44:604-24.
41. Newhouse PA, Krishnan KRR, Doraiswamy PM, et al. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry. 2000;61;559-68.
42. Rascertti K. Drug utilization review of concomittant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Ther. 1995;17:786-90.
43. Bertschy G, Ragama-Pardos E, Muscionico M, et al. Trazodone addition for insmonia in venlafaxine-treated depressed inpatients: a semi-naturalistic study. Pharmacol Res. 2005;51:79-84.
44. Conde V, Escriba JA, Izquierdo J. Evaluación estadística y adaptación castellana de la escala autoaplicada para la depresión de Zung. Arch Neurobiol. 1970;33:185-206.
45. Feighner JP. Maintenance antidepressant therapy: a double-blind comparison of Trazodone and imipramine. J Clin Psychopharmacol. 1981;1 Suppl 6:45-8.
46. Blacker R. The drug treatment of depression in general practice: a comparison of nocte administration of Trazodone with mianserin, dothiepin and amitriptyline. Psychopharmacology. 1988;95:S18-24.
47. De Wilde J. Trazodone versus amitriptyline. A multicentre, double-blind trial in patients hospitalized for depression. Acta Therapeutica. 1987;13:439-53.
48. Gershon S. Evaluation of Trazodone in the treatment of endogenous depression: results of a multicenter double-blind study. J Clin Psychopharmacol. 1981;1 Suppl 6:39-44.
49. Fabre LF. Trazodone efficacy in depression: a double-blind comparison with imipramine and placebo in day-hospital type patients. Curr Ther Res. 1979;25:827-34.
50. Perry PJ. A comparative trial of fluoxetine versus Trazodone in outpatients with major depression. J Clin Psychiatry. 1989;50:290-4.
51. Moon CAL. Efficacy and tolerability of controlled-realease Trazodone in depression: a large multicentre study in general practice. Curr Med Res Opin. 1990;12:160-8.
52. Wheatley D. Trazodone in depression. Int Pharmacopsychiatry. 1980;15:240-46.
53. Wheatley D. Trazodone: alternative dose regimens and sleep. Pharmacotherapeutica. 1983;3:607-12.